Company profile: CoreMap
1.1 - Company Overview
Company description
- Provider of advanced diagnostic technology for electrophysiologists and patients, offering CoreMap Ultra-High Resolution Electrodes to map atrial tissue electrical properties with high spatial resolution and aid identification of AF drivers, and Tissue Property Mapping to sequentially map tissue electrical properties, overcoming limitations of activation mapping.
Products and services
- Tissue Property Mapping: A sequential method mapping atrial tissue electrical properties, allowing sequential data acquisition and overcoming activation mapping limitations
- CoreMap Ultra-High Resolution Electrodes: Custom-engineered electrodes architected to map atrial tissue electrical properties with high spatial resolution, supplying data that aids identification of atrial fibrillation drivers
- Advanced Diagnostic Technology: Clinical-grade offering delivering diagnostic technology to electrophysiologists and patients, leveraging tissue property mapping and ultra-high resolution electrodes to improve patient outcomes by pinpointing atrial fibrillation drivers
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CoreMap
Fluidx Medical Technology
HQ: United States
Website
- Description: Provider of embolic devices and platforms for targeted vessel occlusion, designed for ease of use and delivery control, including GPX liquid embolic for deep occlusion in oncology and other uses; ULTRA peripheral embolic products with varied occlusion levels for hemorrhage; IMPASS neurovascular embolic for deep, distal penetration and middle meningeal artery embolization; and GPX-Clear with non-artifact radiopacity that dissipates for unobstructed visibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluidx Medical Technology company profile →
InterVene
HQ: United States
Website
- Description: Provider of minimally invasive medical devices and therapies for chronic venous disease, particularly deep vein valve failure. The company's BlueLeaf™ Endovenous Valve Formation System offers a non-implantable solution to address severe venous conditions in the legs, aiming to improve patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InterVene company profile →
Farapulse
HQ: United States
Website
- Description: Provider of catheter-based pulsed field ablation tools to treat atrial fibrillation, including the FARAPULSE PFA System that selectively ablates cardiac tissue with pulsed electric fields to minimize damage to surrounding tissues; the FARAWAVE catheter for pulmonary vein isolation in paroxysmal AF; the FARADRIVE steerable sheath for percutaneous catheter introduction; and the FARASTAR generator delivering pulsed fields.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Farapulse company profile →
Nanostim
HQ: United States
Website
- Description: Provider of early-stage medical device technology aimed at preventing complications related to pacemakers, addressing more than 100,000 annual incidents. The company has assembled a world-class team of experienced medical device engineers to bring this technology to market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanostim company profile →
Enchannel
HQ: China
Website
- Description: Provider of one-stop atrial fibrillation treatment solutions, offering the NanoAblate pulsed field ablation generator for non-thermal cardiac ablation; PFLine and PFBasket ablation catheters for flexible lesion sets and pulmonary vein isolation; and the DePolar 4D cardiac mapping system with DipperStar and LibStar catheters for real-time, high-resolution mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enchannel company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CoreMap
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CoreMap
2.2 - Growth funds investing in similar companies to CoreMap
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CoreMap
4.2 - Public trading comparable groups for CoreMap
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →